Back to search

Effect of Suramin on Human Prostate Cancer Cells in Vitro

Data up to Jan 2025

Published1991
Citations75
References28

Total Citations Per Year

Abstract

References (28)

Measurement of protein using bicinchoninic acid

1985 • 17,516 citations

Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate

1987 • 2,447 citations

LNCaP model of human prostatic carcinoma.

1983 • 1,749 citations

Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

1979 • 1,595 citations

Isolation of a human prostate carcinoma cell line (DU 145)

1978 • 1,176 citations

Purification of a Human Prostate Specific Antigen

2016 • 844 citations

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.

1985 • 752 citations

PURIFICATION OF HUMAN PROSTATE SPECIFIC ANTIGEN

1979 • 547 citations

Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells

1987 • 387 citations

Suramin: an anticancer drug with a unique mechanism of action.

1989 • 370 citations

Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture.

1984 • 315 citations

Suramin: With Special Reference to Onchocerciasis

1978 • 291 citations

Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung.

1981 • 208 citations

Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids

1988 • 139 citations

Clinical Pharmacokinetics of Suramin in Patients With HTLV‐III/LAV Infection

1986 • 138 citations

Constitutive production of platelet-derived growth factor-like proteins by human prostate carcinoma cell lines.

1988 • 95 citations

Antiproliferative effects of suramin on lymphoid cells.

1987 • 89 citations

Suramin in Adrenal Cancer: Modulation of Steroid Hormone Production, Cytotoxicityin Vitro, and Clinical Antitumor Effect*

1990 • 87 citations

Measurement of prostate-specific antigen by radioimmunoassay.

1984 • 80 citations

Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat.

1980 • 79 citations

The Effect of Serum Prolactin on Plasma Adrenal Androgens and the Production and Metabolic Clearance Rate of Dehydroepiandrosterone Sulfate in Normal and Hyperprolactinemic Subjects

1986 • 71 citations

Use of Suramin in Treatment of Prostatic Carcinoma Refractory to Conventional Hormonal Manipulation

1991 • 60 citations

The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer

1989 • 57 citations

Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro.

1989 • 54 citations

Quantification of Suramin by Reverse-Phase Ion-Pairing High-Performance Liquid Chromatography

1985 • 44 citations

Effects of Suramin on the Function and Structure of the Adrenal Cortex in the Cynomolgus Monkey

1987 • 41 citations

Immunochemical evaluation of the organ specificity of prostatic acid phosphatase.

1981 • 41 citations

The Partial Dependency of Human Prostatic Growth Factor on Steroid Hormones in Stimulating Thymidine Incorporation into Dna

1987 • 32 citations

Cited By (0)

No citing papers found in database

Effect of Suramin on Human Prostate Cancer Cells in Vitro (1991) – The Journal of Urology | Metascience Observatory Explorer